We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Tuesday broker round-up

Tue, 09th Mar 2021 13:05

(Sharecast News) - Aston Martin: HSBC upgrades to buy with a target price of 2,750p.

Pearson: Berenberg reiterates sell with a target price of 500p.

Gamesys Group: Berenberg reiterates buy with a target price of 1,700p.

Forterra: Canaccord reiterates buy with a target price of 272p.

Ideagen: Canaccord reiterates buy with a target price of 310p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,000p.

GSK: Deutsche Bank reiterates sell with a target price of 1,150p.

Avast: Goldman Sachs reiterates buy with a target price of 600p.

Keller Group: Liberum reiterates buy with a target price of 1,070p.

RPS Group: Liberum reiterates buy with a target price of 100p.

Cairn Energy: Peel Hunt reiterates add with a target price of 225p.

DFS Furniture: Peel Hunt reiterates buy with a target price of 320p.

Travis Perkins: JP Morgan reiterates neutral with a target price of 1,460p.

Clarkson: JP Morgan reiterates neutral with a target price of 2,756p.

RHI Magnesita: Barclays reiterates overweight with a target price of 3,400p.

S4 Capital: Barclays initiates at equal weight with a target price of 475p.

Network International: Jefferies reiterates hold with a target price of 410p.

Related Shares

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.